Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at Diacomit har vist sig effektivt til behandling af SMEI, dog kun i undersøgelser, der var begrænsede og ikke varede så længe, som udvalget havde forventet.
The Committee for Medicinal Products for Human Use (CHMP) concluded that Diacomit had shown its effectiveness in SMEI, albeit in studies that were limited and did not last as long as the Committee expected.